New York Life Investment Management’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-82,000	Closed	-$495K	–	1346
2022 Q4	$495K	Buy	82,000 +8,607	+12%	+$52K	0.01%	941
2022 Q3	$485K	Buy	73,393 +5,808	+9%	+$38.4K	0.01%	767
2022 Q2	$353K	Buy	+67,585	New	+$353K	﹤0.01%	1081